/
BBNX
$17.00+$0.18 (+1.07%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$749.5M
45M shares
52-week range
$8.80 – $32.71
34% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
CS
Borrow rate
0.44%
Easy to borrow
Price (6 mo)
Loading chart…
Change$-6.63
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Revenue | $179.0K | $12.0M | $65.1M | $100.3M |
| Cost of revenue | $0 | $5.7M | $29.2M | $44.7M |
| Gross profit | $179.0K | $6.3M | $35.9M | $55.5M |
| Gross margin | 100.0% | 52.6% | 55.1% | 55.4% |
| R&D | $31.4M | $17.9M | $26.2M | $34.8M |
| Operating income | −$65.8M | −$35.9M | −$45.3M | −$71.7M |
| EBITDA | −$63.4M | −$42.9M | −$53.6M | −$70.3M |
| Net income | −$64.8M | −$44.1M | −$54.8M | −$73.2M |
| Net margin | -36173.7% | -367.6% | -84.1% | -73.0% |
| EPS (diluted) | -12.96 | -8.31 | -8.60 | -1.81 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $134M | $-2.18 | $-2.33–$-1.78 | 6 |
| 2027 | $181M | $-2.14 | $-2.66–$-1.65 | 6 |
| 2028 | $252M | $-1.54 | $-2.06–$-1.04 | 8 |
| 2029 | $343M | $-1.15 | $-1.21–$-1.08 | 6 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
Beta Bionics, Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
www.betabionics.com- Employees
- 423
- IPO / List date
- Jan 30, 2025
- HQ
- IRVINE, CA
Held by traders on TradeandTell
No one on the platform currently holds BBNX.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2025-09-30 | 22,500 | $447.1K |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded BBNX yet.
